A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Public ClinicalTrials.gov record NCT07184944. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, randomized, double-blind, placebo-controlled, maintenance, Phase 3 study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease (CD). Study details include: The study duration may be up to 286 weeks including: * 40-week Pivotal Maintenance Sub-Study * 240-week Open-Label Extension (OLE) Sub-Study * 45-day Follow-Up visit Note: For the participants who do not enroll into OLE Sub-Study, the duration will be up to 46 weeks, including the 40-week maintenance period and a 45-day follow-up visit. The treatment duration may be up to 280 weeks including: * 40 weeks in the Pivotal Maintenance Sub-Study * 240 weeks in OLE Sub-Study The total number of on-site visits will be up to 43: - 21 visits in the Pivotal Maintenance Sub-Study - 22 visits in the OLE Sub-Study
Study identification
- NCT ID
- NCT07184944
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 751 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 16 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 21, 2026
- Primary completion
- Aug 12, 2029
- Completion
- Mar 19, 2034
- Last update posted
- Sep 22, 2026
2026 – 2034
United States locations
- U.S. sites
- 34
- U.S. states
- 14
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Peak Gastroenterology Associates - Colorado Springs-Site Number: 8400039 | Colorado Springs | Colorado | 80907 | Recruiting |
| Clinical Research of Osceola-Site Number: 8400013 | Kissimmee | Florida | 34741 | Recruiting |
| Columbus Clinical Services LLc-Site Number: 8400038 | Miami | Florida | 33125 | Recruiting |
| Bioresearch Partner-Kendale Lakes-Site Number: 8400053 | Miami | Florida | 33175 | Recruiting |
| Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084 | Orlando | Florida | 32806 | Recruiting |
| NMC Research LLC-Site Number: 8400033 | Tampa | Florida | 33607 | Recruiting |
| Illinois Gastroenterology Group d/b/a GI Alliance - Gurnee-Site Number: 8400049 | Gurnee | Illinois | 60031 | Recruiting |
| Gastroenterology Health Partners, PLLC - New Albany-Site Number: 8400100 | New Albany | Indiana | 47150 | Recruiting |
| GI Alliance - Baton Rouge-Site Number: 8400129 | Baton Rouge | Louisiana | 70809 | Recruiting |
| Texas Digestive Disease Consultants, PLLC d/b/a GI Alliance - Mandeville-Site Number: 8400128 | Mandeville | Louisiana | 70471 | Recruiting |
| GI Alliance - Metairie-Site Number: 8400124 | Metairie | Louisiana | 70006 | Recruiting |
| Delta Research Partners-Site Number: 8400087 | Monroe | Louisiana | 71291 | Recruiting |
| BVL Clinical Research-Site Number: 8400005 | Liberty | Missouri | 64068 | Recruiting |
| Gateway Gastroenterology-Site Number: 8400097 | St Louis | Missouri | 63141 | Recruiting |
| MedTraits NY-Site Number: 8400045 | Maspeth | New York | 11378 | Recruiting |
| NYU Langone Health-Site Number: 8400091 | New York | New York | 10016 | Recruiting |
| Weill Cornell Medicine - NewYork-Presbyterian Hospital-Site Number: 8400040 | New York | New York | 10065 | Recruiting |
| New York Gastroenterology Associates-Site Number: 8400009 | New York | New York | 10075 | Recruiting |
| UNC Hospitals, The University of North Carolina at Chapel Hill-Site Number: 8400074 | Chapel Hill | North Carolina | 27514 | Recruiting |
| Cross Creek Medical Clinic-Site Number: 8400057 | Fayetteville | North Carolina | 28304 | Recruiting |
| Ohio Gastroenterology Group Inc.-Site Number: 8400006 | Columbus | Ohio | 43202 | Recruiting |
| Medical Associates Research Group-Site Number: 8400063 | Columbus | Ohio | 43210 | Recruiting |
| OSU Wexner Medical Center-Site Number: 8400077 | Columbus | Ohio | 43210 | Recruiting |
| North Shore Gastroenterology Research-Site Number: 8400130 | Westlake | Ohio | 44145 | Recruiting |
| University of Pennsylvania School of Medicine-Site Number: 8400072 | Philadelphia | Pennsylvania | 19104-6243 | Recruiting |
| The Allegheny Health Network (AHN) Center for Digestive Health-Site Number: 8400107 | Pittsburgh | Pennsylvania | 15212 | Recruiting |
| University Gastroenterology - GI Alliance-Site Number: 8400103 | Providence | Rhode Island | 02904 | Recruiting |
| GI Alliance - Lubbock-Site Number: 8400092 | Lubbock | Texas | 79410 | Recruiting |
| SMS Clinical Research-Site Number: 8400035 | Mesquite | Texas | 75149 | Recruiting |
| Gastroenterology Research of San Antonio LLC-Site Number: 8400054 | San Antonio | Texas | 78229 | Recruiting |
| Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake-Site Number: 8400101 | Southlake | Texas | 76092 | Recruiting |
| Tyler Research Institute LLC-Site Number: 8400095 | Tyler | Texas | 75701 | Recruiting |
| The Vancouver Clinic Inc. P.S.-Site Number: 8400090 | Vancouver | Washington | 98664 | Recruiting |
| Gastroenterology Associates of Western Michigan-Site Number: 8400060 | Wyoming | Wyoming | 49519 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07184944, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 22, 2026 · Synced Sep 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07184944 live on ClinicalTrials.gov.